Pelthos Therapeutics Inc. (PTHS) — Stock Score Summary

Pelthos Therapeutics Inc. (PTHS) has a MoatMap StockRank of 12/100 based on Quality (21/100), Value (32/100), and Momentum (43/100) factor scores. The current signal is STRONG SELL. Pelthos Therapeutics is a micro-cap healthcare play with insufficient operational history and no alignment with our high-conviction CDMO theme.

Pelthos Therapeutics Inc. is a clinical-stage biotechnology company focused on developing and commercializing novel therapeutics for infectious diseases and other unmet medical needs. The company's competitive position is anchored by its proprietary drug development platforms and targeted intellectual property portfolio. It operates as a specialized niche player in the biopharmaceutical sector, navigating clinical trials to bring first-in-class treatments to market.

Key Financial Metrics

Price$26.90
Market Cap$90M
P/E (Forward)-12.17
Price/Book2.48
Return on Equity-333.8%
Return on Invested Capital-45.7%
Debt/Equity150.79
Gross Margin75.2%
Operating Margin-120.0%
Free Cash Flow$-34M

Pelthos Therapeutics Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Pelthos Therapeutics Inc.’s (PTHS) StockRank?
MoatMap’s StockRank for Pelthos Therapeutics Inc. (PTHS) is 12/100, with a Strong Sell signal. It is a composite of Quality (21), Value (32), and Momentum (43) factor ranks across MoatMap’s 19,000+ stock universe.
Does Pelthos Therapeutics Inc. have an economic moat?
Pelthos Therapeutics Inc. (PTHS) has a Quality factor score of 21/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Pelthos Therapeutics Inc. a buy, hold, or sell?
MoatMap’s current signal for Pelthos Therapeutics Inc. (PTHS) is Strong Sell, based on a StockRank of 12/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Pelthos Therapeutics Inc. in?
Pelthos Therapeutics Inc. (PTHS) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksPTHS deep dive reportAI ChampionsHow we score stocksSense-check another stock